V. Bryan Lawlis, Director at BIOMARIN PHARMACEUTICAL INC (BMRN), sold 8,500 shares at $87.61 ($745K) on 2022-01-14, disclosed to the SEC on 2022-01-19.
Open-market sale of $745k BMRN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $87.61 | 4,250 | $372K | 50.0% |
| 2 | $87.61 | 4,250 | $372K | 50.0% |
| Total | $87.61 avg | 8,500 | $745K | 100% |
| Filing → |
| GERN | SELL | 2023-05-11 | $105K | — | Filing → |
| BMRN | SELL | 2023-04-04 | $825K | — | Filing → |
| BMRN | SELL | 2022-04-18 | $356K | — | Filing → |